CDMO– tag –
-
APAC’s Bioprocessing Technology Ready, Regulatory Certainty Needed for Continuous Manufacturing Investment; China/Korea CDMOs Lead Adoption
BioProcess International USA Overview A BioProcess International article analyzes regulatory challenges for continuous and intensified bioprocessing adoption in the Asia Pacific (APAC) region. While hardware and software for perfusion bi... -
Global Pharma and Biotech Firms Intensify Investment in Biologics Contract Manufacturing Market, openPR.com Reports
openPR.com USA Overview Global pharmaceutical and biotechnology companies are significantly increasing their investments in the biologics contract manufacturing (CDMO) market, as reported by openPR.com. FUJIFILM Diosynth Biotechnologies ... -
Bora Biologics Expands US Biologics Manufacturing Capacity to 20,000 Liters with New Rockville, Maryland Site
PharmaSource USA Overview Bora Biologics has expanded its U.S. drug substance manufacturing platform by adding a new site in Rockville, Maryland. This expansion increases its single-use bioreactor capacity to 20,000 liters, with scalabil... -
Cytovance Biologics Enhances Biologics Manufacturing Process Development with Perfusion Capabilities to Boost Productivity
Cytovance Biologics USA Overview Cytovance Biologics, a CDMO, has expanded its upstream process development services by integrating perfusion capabilities. This technological addition enables higher productivity, extended cell culture du... -
Lonza Offers Integrated ADC Clinical and Commercial Manufacturing Services, Covering Antibody to Sterile Fill-Finish
Lonza Switzerland Overview Lonza offers integrated development and manufacturing services for Antibody-Drug Conjugates (ADCs), encompassing antibodies, payloads, bioconjugation, and sterile fill and finish. The company operates GMP produ... -
Shantha Biologics Secures Fill-Finish Manufacturing Agreement with Novo Nordisk for Cartridge Injectables in India
European Pharmaceutical Review India Overview Shantha Biologics has signed an agreement with Novo Nordisk to provide cartridge fill-finish manufacturing services in India. This collaboration strengthens Shantha's role in supporting pharm... -
Lonza Expands Strategic Collaboration with Leading U.S. Biopharmaceutical Company, Adding Two Biologic Programs for Commercial Production and Enhancing Manufacturing with N-1 Perfusion Technology
Lonza Press Release Switzerland Overview Lonza has announced an expanded strategic collaboration with a leading U.S. biopharmaceutical company, adding two new biologic programs for commercial production. This multi-year agreement leverag... -
Lonza Accelerates DNA-to-IND Programs with New GS Ori‑Go™ Vector Technology: Delivers Tox Material in 2 Months, IND-Ready in as Fast as 6 Months
Lonza Press Release Switzerland Overview Lonza announced the enhancement of its preclinical development services, featuring the new GS Ori‑Go™ vector technology, to significantly accelerate DNA-to-IND (Investigational New Drug) programs.... -
CDMO World Releases Validation Guide for Machine Learning in Bioreactor Optimization, Emphasizing Real-Time Control and Data Governance
CDMO World USA Overview CDMO World has published a validation guide analyzing the operational benefits and data integrity risks of applying machine learning (ML) to bioreactor optimization in commercial fermentation processes. The guide ... -
Drug Discovery News Analyzes Viral Vector Manufacturing Scale-Up Challenges for Gene Therapies, Highlighting AAV Production Bottlenecks
Drug Discovery News USA Overview Drug Discovery News focuses on the significant scale-up challenges in viral vector manufacturing for gene therapies, particularly emphasizing bottlenecks in adeno-associated virus (AAV) production. The ar...
